English
Specials
    Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsOpinionMedPlus’ own branded product business needs close monitoring by investors

    MedPlus’ own branded product business needs close monitoring by investors

    Success of the private label pharma products can improve MedPlus’ profitability and accelerate generic drug adoption in India

    R. Sree Ram
    June 24, 2024 / 08:21 IST
    Customer retention is vital for the long-term success of the private label business
    • PRO Panorama

      Moneycontrol Pro Panorama | Tariff noise, empty vessel?

      Oct 17, 2025 / 02:40 PM IST

      For Moneycontrol's Pro Panorama October 17 edition: Tea drinkers rejoice but growers balk at price side, decoding India's trade de...

      Read Now
    Unlock This Article

    Are you a PRO subscriber? Sign In

    What Do You Get

    • Ad free Experience

      Seamless navigation, faster responses.

    • Expert Perspective

      Explore 230+ exclusive editorials every month

    • +

      Uncover Insights from World-Renowned Experts and Journalists

    • Actionable Insights

      40+ weekly investment ideas + 3 to 4 daily technical calls

    • Virtual Events

      Exclusive Live Webinars for Expert Trading & Investment Strategies!

    • Newsletters

      Stay ahead with daily and weekly insights

    View Offers

    Unlock exclusive discounts